The pathological assessment of colorectal adenocarcinomas has remained essentially unchanged during the past 50 years. The staging system (Dukes, 1932) which depends on the depth of tumour invasion and presence or absence of lymph node metastases has survived since 1932 and although various modifications have been proposed (Kirklin et al., 1949; Astler & Coller, 1954; Turnbull et al., 1967; Feinstein et al., 1975; Wood et al., 1981) these have failed to gain universal acceptance. The Dukes's staging system is usually combined with subjective grading of the extent of tumour differentiation (Stewart & Spies, 1929; Dukes, 1936; Grinnel, 1939) to determine the final prognosis.
The tumour stage-may be regarded as an index of how far a tumour has progressed in its natural history. It does not assess the biological aggressiveness or growth rate which at present is gauged from the differentiation of a tumour in the belief that poor differentiation equates with enhanced growth potential. However, the assessment of differentiation is entirely subjective and colorectal tumours have previously been shown to be markedly heterogeneous in this respect (Qualheim & Gall, 1953 of a tumour and thus assessment of its biological aggressiveness has not been previously studied in detail, but clearly could have a significant bearing on the final prognostic index determined.
It has recently been suggested that the assessment of colorectal adenocarcinomas by flow cytometry may add an important new prognostic dimension. One study (Wolley et al., 1982) demonstrated that the five year survival of patients with diploid or near diploid tumours (65%) was almost nine times that of patients with non-diploid tumours (7.5%). However, other workers using similar methods have demonstrated marked heterogeneity of DNA content within colorectal tumours, with more than one clone being present in a large proportion of cases (31-60%) (Peterson et al., 1980; Rognum et al., 1982; Tribukait et al., 1983) . The finding of such DNA heterogeneity raises the question as to whether a single sample will suffice to accurately assess the ploidy status of a tumour, as has previously been proposed (Wolley et al., 1982) .
An important growth parameter not adequately assessed in previous studies of colorectal cancers is the large proportion of dead and dying cells. In many solid tumours the cell death rate may comprise between 50 and 99% of the tumour cell population (Steel, 1967; Refsum & Berdal, 1967; Iverson, 1967; Frindel et al., 1968; Cooper et al., 1975) . Any attempts to refine assessments of the growth potential of tumours by flow cytometric or (j The Macmillan Press Ltd., 1985 morphological methods must include estimates of the proportion of dying cells (Alabaster et al., 1980; Frindel et al., 1968) .
For these reasons we have employed in this study a combination of a newly developed flow cytometric technique (Dyson et al., 1984a; 1984b; 1984c) with conventional histopathological assessments of primary and metastatic colorectal adenocarcinomas. We have attempted to determine the extent of tumour heterogeneity and the proportion of dying cells to assess their influence on tumour staging and grading. In conducting histopathological assessments of tumour grade we have evaluated whether interobserver variation can be reduced and agreement between grade and DNA content increased by estimating the proportions occupied by different grades in multiple samples of individual tumours. We have also attempted to correlate the flow cytometric results with conventional histopathological assessments to determine whether they can refine or replace current staging and grading procedures.
Materials and methods

Sampling
Fifty consecutive surgically resected specimens of colorectal adenocarcinoma were obtained fresh and two superficial and two deep samples taken from opposite poles of each tumour; sixteen enlarged lymph nodes containing metastatic deposits were also obtained from ten of the specimens (Figure 1) The stained sections from the various samples were randomised, coded and graded independently by three pathologists, using established criteria (Grinnell, 1939) . In addition each observer estimated the proportion (expressed as a percentage) of well, moderate or poorly differentiated adenocarcinoma in the four samples from each tumour and the "final grade" was obtained by averaging the results from the three observers. When this produced equal proportions of two or more grades then the least differentiated grade was allotted as the final grade. This novel grading system was developed in an attempt to minimise interobserver error and to increase the chance of agreement with flow cytometric data where results are quantitative. The method also takes account of the heterogeneous nature of colorectal adenocarcinomas and avoids the conventional pathological practice of grading simply on the worst differentiated area for which there is no verified prognostic basis. 
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Grading analysis When grading tumours, variation can occur due to interobserver error and tumour heterogeneity. To assess the interobserver variation kappa statistics were applied using previously described methods for colorectal adenocarcinomas (Thomas et al., 1983) Tissue samples measuring 0.5 cm3 were stored in HBSS at 4°C until analysis, which was normally conducted within 24h of removal. Periodic measurements were also carried out on samples stored at 40C for up to 72h with no significant alteration in the diploid or non-diploid fractions; increases (4-10%) in the proportion of dead and dying cells occurred only after 48h. After removal, tissue was minced by scalpel and suspended in 4 ml Hepes buffer pH 7.3, containing 1 mM Ca2' and 200 units collagenase (Sigma Chemical Company, Poole BH17 7NH). The suspension was incubated in a shaking water bath for 0.5-1 h at 37°C. Cells were then collected by centrifugation, suspended in 2ml PBS and incubated with 1 unit of papain (Sigma, Type III) for 5min at 37°C in 2 ml of PBS. Cells were again collected by centrifugation and resuspended in 2-4 ml of PBS (50%) and HBSS (50%); an equal volume of the same medium was then added containing 15,uM acridine orange (AO) and the sample was placed in the flow cytometer and the sample flow started and allowed to equilibriate. Figure  2 and were modified from our previous studies (Dyson et al., 1984a (Dyson et al., , 1984b (Dyson et al., , 1984c to allow for the wider range of DNA content seen in these tumours. Table IV . It can be seen that there is no consistent difference between superficial and deep regions of the tumour. However, considerable heterogeneity was observed within individual tumours as illustrated in Figure 5 . To determine the effect of tumour heterogeneity on flow cytometric assessments we ascertained how often all four samples fell into either the diploid or non-diploid groups. It was found that 36 tumours (72%) would have been correctly assigned on the basis of any one sample whereas 14 tumours (28%) could have been incorrectly designated since one of the samples fell into a different ploidy group from the others. If the tumours were further subdivided into three subgroups (<10%, 10-30%, >30% of Cell death Previous studies have confirmed the validity of using ethidium bromide staining to determine the level fo cell death in vivo and in vitro (Dyson et al., 1984a (Dyson et al., , 1984b (Dyson et al., , 1984c . The range of values found in the various tumours (8-92%) was the greatest of any of the areas quantitated ( Figure  4) . However, within individual tumours variation was the lowest of the four areas quantitated (see Figure 5 ). The mean number of dead and dying cells was 53.7%. 
Discussion
Our technique of flow cytometric analysis of colorectal adenocarcinomas by staining unfixed whole cells with acridine orange and ethidium bromide has substantiated the findings of others using fixed or unfixed stripped nuclei (Petersen et al. 1980; Linden et al., 1980; Wolley et al., 1982; Rognum et al., 1982; Tribukait et al., 1983; Frankfurt et al., 1984) . We have confirmed that a wide range of DNA content is exhibited by these tumours and that comparable results can be obtained with both primary and metastatic tumours. However, our approach differs from that of previous workers in that we have used scattergrams of DNA and RNA concentration for analysis rather than DNA histograms. The former method is more sensitive allowing the presence of small numbers of cells in any area to be recognised more readily and by the careful quantitation of cell number above 4.5c we have removed the subjectivity of assessing the presence or absence of an aneuploid Go and G1 peak or peaks. However, the relative merit of quantitation of a scattergram or the recognition of a second Go G, peak on a DNA histogram as an index of DNA abnormality and possible prognosis must await longer term survival data.
In this study we have demonstrated heterogeneity in the DNA content of multiple samples from the same tumour confirming the results of other workers (Petersen et al., 1980; Rognum et al., 1982 (Steel, 1967; Iverson, 1967; Refsum & Berdal, 1967; Cooper et al., 1975) and approximates closely to the figure of 60% suggested for adenocarcinomas. Whilst this data is not strictly comparable the wide variation in the proportion of dying cells (8-92%) within these tumours indicate the necessity of determining the extent of cell death if the growth potential of tumours is to be accurately assessed.
The percentage histological grading system developed for this study did not reduce the interobserver error when compared with routine grading systems although using three observers to allocate an averaged grade minimised individual variations and allowed a more objective assessment of tumour heterogeneity. It did, however, result in an increased number of tumours being placed in a poorer histological grade. This may reflect the fact that more detailed study of multiple samples emphasises regions of poorer differentiation that are less obvious when fewer samples are studied. Over half the tumours (56%) also exhibited differences in grade in one or more samples confirming that heterogeneity of grade is of common occurrence in colorectal adenocarcinomas. Such heterogeneity may explain the poor agreement obtained between the grade observed in preoperative biopsies and the subsequently resected tumour (Chapuis et al., 1982) .
Our failure in this study to find differences by histopathology and flow cytometry between randomised superficial and deep samples disproves the concept that the deeper advancing edges of colorectal cancers are poorer differentiated than their more superficial counterparts.
Despite the use of improved flow cytometric techniques and methods of histological grading that take account of regional variations in differentiation within tumours, we have failed like others to demonstrate a correlation between the DNA content and histological grade. As regards the relationship of stage to DNA abnormality, we found that Dukes's B stage tumours contained a higher number of cells in Area 3 than Dukes's C tumours (P<0.05). This finding is based on relatively small numbers and requires further investigation, but the absence of a direct relationship between DNA abnormality and advancing stage is not entirely unexpected, as the stage of a tumour is an index of its progression and not of its growth rate or biological aggressiveness.
